- Home
- DRCT vs MTNB Comparison
DRCT vs MTNB Comparison
Compare DRCT & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRCT
- MTNB
- Stock Information
- Founded
- DRCT 2018
- MTNB 2013
- Country
- DRCT United States
- MTNB United States
- Employees
- DRCT N/A
- MTNB N/A
- Industry
- DRCT Computer Software: Programming Data Processing
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- DRCT Technology
- MTNB Health Care
- Exchange
- DRCT Nasdaq
- MTNB Nasdaq
- Market Cap
- DRCT 9.2M
- MTNB 7.9M
- IPO Year
- DRCT 2022
- MTNB N/A
- Fundamental
- Price
- DRCT $0.46
- MTNB $1.82
- Analyst Decision
- DRCT Strong Buy
- MTNB Hold
- Analyst Count
- DRCT 1
- MTNB 1
- Target Price
- DRCT $6.00
- MTNB N/A
- AVG Volume (30 Days)
- DRCT 791.3K
- MTNB 1.4M
- Earning Date
- DRCT 08-05-2025
- MTNB 08-14-2025
- Dividend Yield
- DRCT N/A
- MTNB N/A
- EPS Growth
- DRCT N/A
- MTNB N/A
- EPS
- DRCT N/A
- MTNB N/A
- Revenue
- DRCT $36,459,000.00
- MTNB N/A
- Revenue This Year
- DRCT $16.81
- MTNB N/A
- Revenue Next Year
- DRCT $62.96
- MTNB N/A
- P/E Ratio
- DRCT N/A
- MTNB N/A
- Revenue Growth
- DRCT N/A
- MTNB N/A
- 52 Week Low
- DRCT $0.38
- MTNB $0.47
- 52 Week High
- DRCT $6.59
- MTNB $4.67
- Technical
- Relative Strength Index (RSI)
- DRCT 48.77
- MTNB 56.95
- Support Level
- DRCT $0.44
- MTNB $1.89
- Resistance Level
- DRCT $0.48
- MTNB $2.24
- Average True Range (ATR)
- DRCT 0.04
- MTNB 0.37
- MACD
- DRCT 0.01
- MTNB 0.01
- Stochastic Oscillator
- DRCT 75.24
- MTNB 27.84
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.